Life Openers™ Toolkit
A PAD strategy that drives modern vessel preparation and treatment
Potential clinical pathway
A PAD strategy that drives modern vessel preparation and treatment
Talk to a BD specialistOur solutions
Technologies like Rotarex™, UltraScore™, Lutonix™, and LifeStent™ enable tailored, effective treatment strategies
Rotarex™S
Rotational Artherothrombobectomy System
Clinical use
- Removal of thrombotic, thromboembolic, and atherothrombotic material from fresh, subacute, and chronic occlusions of peripheral blood vessels
- Indicated for native vessels, stents (in-stent reocclusion), native/artificial bypasses, and dialysis access
- Applicable in arteries and veins, excluding cardiopulmonary, coronary, and cerebral circulations
Key-features and benefits
- Four-in-one function: detachment, aspiration, fragmentation, and removal of occluding material
- Efficient debulking for acute to chronic occlusions
- Continuous aspiration for minimized distal embolization risk
- Suitable for a wide range of vessel sizes and occlusion types
- Multiple French sizes (6F, 8F, 10F) to match vessel anatomy
UltraScore™
Focused Force PTA Ballon
Clinical use
- Dilatation of stenoses in iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries
- Treatment of obstructive lesions in native/synthetic arteriovenous dialysis fistulae
- Post-dilatation of balloon-expandable/self-expanding stents and stent grafts in the peripheral vasculature
Key-features and benefits
- Focused Force scoring balloon for controlled plaque modification at lower pressures, reducing dissection risk
- GeoAlign™ Marking System for accurate intravascular measurement and geographic alignment. Proven reduction in fluoroscopy time (up to 27 %)
- Hydrophilic coating for improved deliverability
- Broad size range (2–8 mm diameter, 20–300 mm length) and compatibility with .014" and .035" guidewires
Lutonix™035
Drug Coated Balloon PTA Catheter
Clinical use
- Treatment of de-novo or restenotic lesions in the superficial femoral artery (SFA)
- Indicated for complex lesions including calcified, chronic total occlusions, in-stent restenosis, and long lesions (up to 300 mm)
Key-features and benefits
- Paclitaxel dose 2 μg/mm² with polysorbate/sorbitol carrier for optimized drug transfer and minimal downstream particulate
- Level 1 clinical evidence
- Demonstrated high patency rates: e.g., 94.1 % freedom from TLR at 12 months (SFA registry)
- Reduced reintervention rates vs. PTA
- Broad clinical dataset (>400,000 patients treated worldwide)
LifeStent™
Vascular Stent
Clinical use
- Primary stenting of de-novo or restenotic lesions in the native superficial femoral artery (SFA) and proximal popliteal artery
- Designed for symptomatic peripheral arterial disease (PAD) cases, including longer lesions
Key-features and benefits
- Clinically proven helical stent design for flexibility and fracture resistance
- Available in lengths up to 200 mm to treat long lesions with a single stent
- GeoAlign™ Marking System for precise placement
- 5F low-profile delivery system for procedural efficiency
- Demonstrated superior long-term patency over PTA in the resilient Trial (e.g., 87 % freedom from TLR at 12 months)
Join our community and rethink your PAD strategy
Don’t miss out! Agree to receive communications and enjoy exclusive access to clinical data, special events, and content curated just for peripheral arterial disease specialists.